لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Y. Kushchevyi, Y. Pastushenko, Martina Manni, Yana Stepanishyna, I. Kriachok, A. Hubareva, T. Kadnikova, O. Novosad, Massimo Federico, K. Filonenko, O. Aleksik, A.V. Martynchyk, I. Tytorenko, G. R. Galli, N. Shudrak, Tetiana Skrypets

المصدر: Hematological Oncology. 39

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ukrainian, Hematology, General Medicine, medicine.disease, language.human_language, Lymphoma, Preliminary report, Internal medicine, medicine, language, Who classification, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::71c0d1331b0b70a38221c07959a4cc03
https://doi.org/10.1002/hon.108_2881

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: O. Skachkova, Tetiana Skrypets, Irina Kryachok, O. Gorbach, O. Novosad, N. Khranovska, Y. Pastushenko

المصدر: Annals of Oncology. 28:v363-v364

مصطلحات موضوعية: biology, business.industry, Hematology, Transforming growth factor beta, Hodgkin's lymphoma, medicine.disease, Oncology, Interleukin 13, Immunology, biology.protein, Medicine, In patient, business, Indoleamine 2,3-dioxygenase, Transforming growth factor

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9aa6fd67776af846ebd08e89d95565fb
https://doi.org/10.1093/annonc/mdx373.025

المؤلفون: E. Kushchevyy, Tetiana Skrypets, E. Gingsburg, O. Aleksik, K. Ulianchenko, O. Novosad, K. Filonenko, A.V. Martynchyk, V. Jurchishina, I. Titorenko, Irina Kryachok, T. Kadnikova, Y. Pastushenko, Y. Stepanishina, M. Surkis

المصدر: Annals of Oncology. 28:v517

مصطلحات موضوعية: medicine.medical_specialty, Oncology, business.industry, Family medicine, Association (object-oriented programming), Support care, medicine, Hematology, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8baf05baa379007e898848b9c897f7fc
https://doi.org/10.1093/annonc/mdx385.020

المؤلفون: I. Titorenko, I. Kriachok, K. Filonenko, O. Novosad, O. Alexik, T. Kadnikova, A. Martynchik, E. Kuscshevyy, Y. Pastushenko

المصدر: European Journal of Cancer. 47:S648

مصطلحات موضوعية: BEACOPP, Cancer Research, Poor prognosis, Hodgkin s, medicine.medical_specialty, business.industry, medicine.medical_treatment, Disease, Oncology, Multicenter study, Internal medicine, medicine, In patient, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ccd2f17821462a9c43409a55c9fe237a
https://doi.org/10.1016/s0959-8049(11)72496-0

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Kriachok I; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Tytorenko I; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Shudrak N; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Aleksik O; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Stepanishyna Y; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Kadnikova T; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Pastushenko Y; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Shokun N; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Rudiyk T; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine., Bushuieva M; State Non-commercial Enterprise 'National Cancer Institute', Kyiv, Ukraine.

المصدر: Experimental oncology [Exp Oncol] 2024 Feb 03; Vol. 45 (4), pp. 474-482. Date of Electronic Publication: 2024 Feb 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Akademperiodyka Country of Publication: Ukraine NLM ID: 101230541 Publication Model: Electronic Cited Medium: Internet ISSN: 2312-8852 (Electronic) Linking ISSN: 18129269 NLM ISO Abbreviation: Exp Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/diagnosis , Lymphoma, T-Cell, Peripheral*/drug therapy , Lymphoma, T-Cell, Peripheral*/pathology, Humans ; Prospective Studies ; Etoposide/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Treatment Outcome ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/adverse effects ; Doxorubicin/therapeutic use ; Disease Progression

المؤلفون: Kriachok I; National Cancer Institute, Kyiv 03022, Ukraine., Shudrak N; National Cancer Institute, Kyiv 03022, Ukraine., Tytorenko I; National Cancer Institute, Kyiv 03022, Ukraine., Stepanishyna Y; National Cancer Institute, Kyiv 03022, Ukraine., Martynchik A; National Cancer Institute, Kyiv 03022, Ukraine., Aleksik O; National Cancer Institute, Kyiv 03022, Ukraine., Novosad O; National Cancer Institute, Kyiv 03022, Ukraine., Kadnikova T; National Cancer Institute, Kyiv 03022, Ukraine., Pastushenko Y; National Cancer Institute, Kyiv 03022, Ukraine., Kyschevoy E; National Cancer Institute, Kyiv 03022, Ukraine., Shokun N; National Cancer Institute, Kyiv 03022, Ukraine.

المصدر: Experimental oncology [Exp Oncol] 2021 Dec; Vol. 43 (4), pp. 346-350.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Akademperiodyka Country of Publication: Ukraine NLM ID: 101230541 Publication Model: Print Cited Medium: Internet ISSN: 1812-9269 (Print) Linking ISSN: 18129269 NLM ISO Abbreviation: Exp Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Non-Hodgkin*/epidemiology , Lymphoma, Non-Hodgkin*/pathology , Lymphoma, Non-Hodgkin*/therapy , Lymphoma, T-Cell*/epidemiology , Lymphoma, T-Cell*/pathology , Lymphoma, T-Cell*/therapy, Humans ; Prognosis ; Prospective Studies ; T-Lymphocytes/pathology